Quick Links Investor Presentation Responsibility News Portfolio Responsibility Report Annual Reports Leadership Governance SEC Filings Latest Press Releases May 12, 2026 Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 Congress May 7, 2026 Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis May 6, 2026 Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) All press releases Latest Events May 19 2026 May 19 2026 RBC Global Healthcare Conference Click here for Webcast May 13 2026 May 13 2026 BofA Securities Health Care Conference Click here for Webcast Apr 28 2026 Apr 28 2026 Q1 2026 Incyte Corporation Earnings Conference Call Click here for Webcast All events
